C. PoulosA. RiewpaiboonJ. F. StewartJ. ClemensS. GuhM. AgtiniD. SurZ. IslamM. LucasD. WhittingtonRTI InternationalMahidol UniversityThe University of North Carolina at Chapel HillInternational Vaccine Institute, SeoulBadan Penelitian Dan Pengembangan Kesehatan, Kementerian Kesehatan Republik IndonesiaNational Institute of Cholera and Enteric Diseases IndiaInternational Centre for Diarrhoeal Disease Research BangladeshMinistry of Science and TechnologyUniversity of ManchesterUniversitas IndonesiaCentre for Environmental Hygiene and Medical ExaminationUniversity of Washington, SeattleNorth Carolina Central University2018-06-112018-06-112012-03-01Epidemiology and Infection. Vol.140, No.3 (2012), 500-50914694409095026882-s2.0-84856295281https://repository.li.mahidol.ac.th/handle/20.500.14594/14946Economic analyses of cholera immunization programmes require estimates of the costs of cholera. The Diseases of the Most Impoverished programme measured the public, provider, and patient costs of culture-confirmed cholera in four study sites with endemic cholera using a combination of hospital-and community-based studies. Families with culture-proven cases were surveyed at home 7 and 14 days after confirmation of illness. Public costs were measured at local health facilities using a micro-costing methodology. Hospital-based studies found that the costs of severe cholera were US$32 and US$47 in Matlab and Beira. Community-based studies in North Jakarta and Kolkata found that cholera cases cost between US$28 and US$206, depending on hospitalization. Patients' cost of illness as a percentage of average monthly income were 21% and 65% for hospitalized cases in Kolkata and North Jakarta, respectively. This burden on families is not captured by studies that adopt a provider perspective. © 2011 Cambridge University Press.Mahidol UniversityMedicineArticleSCOPUS10.1017/S0950268811000513